CARMAT (FR0010907956, ALCAR, PEA-PME eligible), designer and developer of the most advanced total artificial heart in the world, aimed at offering a therapeutic alternative to patients suffering from end-stage biventricular heart failure, today announces the holding of a videoconference in French on January 31 at 6:00 p.m. (CET) to provide an update on its activities.
Log in by clicking on this link:
https://us02web.zoom.us/webinar/register/WN_A4SonyXDRk-GAdBaIBoEog
• The link above allows you to register for the virtual meeting via Zoom.
• You will then receive a confirmation e-mail containing the access link to the meeting.
• If you don’t have the Zoom app, it will automatically download when you connect.
• At any time during the presentation, you can send your question via the web platform. It will be placed in the queue for the Q&A session.
To receive all of CARMAT’s financial information in real time, send a request by email to [email protected]. Your registration will be immediate.